NO20031838D0 - Benzokazinonderivater, deres fremstilling og anvendelse - Google Patents

Benzokazinonderivater, deres fremstilling og anvendelse

Info

Publication number
NO20031838D0
NO20031838D0 NO20031838A NO20031838A NO20031838D0 NO 20031838 D0 NO20031838 D0 NO 20031838D0 NO 20031838 A NO20031838 A NO 20031838A NO 20031838 A NO20031838 A NO 20031838A NO 20031838 D0 NO20031838 D0 NO 20031838D0
Authority
NO
Norway
Prior art keywords
benzocazine
derivatives
preparation
benzocazine derivatives
Prior art date
Application number
NO20031838A
Other languages
English (en)
Other versions
NO20031838L (no
Inventor
Christopher Norbert Johnson
Harshad Kantilal Rami
Geoffrey Stemp
Kevin Michael Thewlis
Mervyn Thompson
Antonio Kuok Keong Vong
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0026224A external-priority patent/GB0026224D0/en
Priority claimed from GB0111858A external-priority patent/GB0111858D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20031838D0 publication Critical patent/NO20031838D0/no
Publication of NO20031838L publication Critical patent/NO20031838L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO20031838A 2000-10-26 2003-04-24 Benzoksazinonderivater, deres fremstilling av anvendelse NO20031838L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0026224A GB0026224D0 (en) 2000-10-26 2000-10-26 Novel compounds
GB0111858A GB0111858D0 (en) 2001-05-15 2001-05-15 Novel compounds
PCT/EP2001/012344 WO2002034754A2 (en) 2000-10-26 2001-10-22 Benzoxazinone derivatives, their preparation and use

Publications (2)

Publication Number Publication Date
NO20031838D0 true NO20031838D0 (no) 2003-04-24
NO20031838L NO20031838L (no) 2003-06-24

Family

ID=26245199

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031838A NO20031838L (no) 2000-10-26 2003-04-24 Benzoksazinonderivater, deres fremstilling av anvendelse

Country Status (20)

Country Link
US (1) US6939871B2 (no)
EP (1) EP1330460B1 (no)
JP (1) JP4242643B2 (no)
KR (1) KR20030051747A (no)
CN (1) CN1478092A (no)
AR (1) AR034174A1 (no)
AT (1) ATE357448T1 (no)
AU (1) AU2002224791A1 (no)
BR (1) BR0114881A (no)
CA (1) CA2426706A1 (no)
CZ (1) CZ20031163A3 (no)
DE (1) DE60127434T2 (no)
ES (1) ES2280417T3 (no)
HU (1) HUP0301458A2 (no)
IL (1) IL155520A0 (no)
MX (1) MXPA03003820A (no)
NO (1) NO20031838L (no)
PL (1) PL366378A1 (no)
TW (1) TWI237023B (no)
WO (1) WO2002034754A2 (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0203778D0 (en) * 2002-02-18 2002-04-03 Glaxo Group Ltd Compounds
GB0203804D0 (en) 2002-02-18 2002-04-03 Glaxo Group Ltd Compounds
GB0203811D0 (en) * 2002-02-18 2002-04-03 Glaxo Group Ltd Compounds
GB0209244D0 (en) * 2002-04-23 2002-06-05 Glaxo Group Ltd Compounds
WO2004029048A1 (en) * 2002-09-26 2004-04-08 Warner-Lambert Company Llc Heterocyclic substituted piperazines for the treatment of schizophrenia
JP4602903B2 (ja) 2002-10-10 2010-12-22 モルフォケム アクチェンゲゼルシャフト フュア コンビナトリシェ ヘミー 抗菌活性を有する新規化合物
PT1562918E (pt) 2002-11-08 2008-03-12 Hoffmann La Roche Benzoxazinonas substituídas e as suas utilizações
GB0227240D0 (en) * 2002-11-21 2002-12-31 Glaxo Group Ltd Compounds
WO2004062398A1 (ja) 2003-01-10 2004-07-29 Zuiko Corporation 着用物品およびその製造方法
ATE434612T1 (de) * 2003-04-30 2009-07-15 Bayer Cropscience Ag Insektizide (dihalopropenyl)phenylalkyl substituierte dihydrobenzofuran- und dihydrobenzopyran-derivate
GB0310851D0 (en) * 2003-05-12 2003-06-18 Glaxo Group Ltd Compounds
GB0310849D0 (en) * 2003-05-12 2003-06-18 Glaxo Group Ltd Compounds
GB0316915D0 (en) 2003-07-18 2003-08-20 Glaxo Group Ltd Compounds
RU2007107177A (ru) * 2004-07-28 2008-09-10 Айрм Ллк (Bm) Соединения и композиции, как модуляторы ядерных рецепторов стероидных гормонов
WO2007042325A1 (de) * 2005-10-13 2007-04-19 Morphochem Aktiengesellschaft für kombinatorische Chemie 5-chinolinderivate mit antibakterieller aktivität
US8716280B2 (en) 2009-01-21 2014-05-06 Basilea Pharmaceutica Ag Bicyclic antibiotics
JP5697685B2 (ja) 2009-12-18 2015-04-08 バジリア ファルマスーチカ アーゲーＢａｓｉｌｅａ Ｐｈａｒｍａｃｅｕｔｉｃａ ＡＧ 三環式抗生物質
CN103635474B (zh) 2011-06-17 2016-04-27 巴斯利尔药物股份公司 三环抗生素
AR111295A1 (es) 2017-03-20 2019-06-26 Forma Therapeutics Inc Composiciones de pirrolopirrol como activadores de piruvato quinasa (pkr)
WO2020061255A1 (en) 2018-09-19 2020-03-26 Forma Therapeutics, Inc. Activating pyruvate kinase r
US20200129485A1 (en) 2018-09-19 2020-04-30 Forma Therapeutics, Inc. Treating sickle cell disease with a pyruvate kinase r activating compound
MX2022003025A (es) 2019-09-19 2022-04-07 Forma Therapeutics Inc Activacion de la piruvato cinasa r.
US12128035B2 (en) 2021-03-19 2024-10-29 Novo Nordisk Health Care Ag Activating pyruvate kinase R

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI0906294T1 (en) * 1996-05-29 2003-04-30 Warner-Lambert Company Benzoxazinone dopamine d4 receptor antagonists
EP0900792B1 (en) 1997-09-02 2003-10-29 Duphar International Research B.V Piperazine and piperidine derivatives as 5-HT1A and dopamine D2-receptor (ant)agonists
WO2000040581A1 (en) 1999-01-07 2000-07-13 American Home Products Corporation 3,4-dihydro-2h-benzo[1,4]oxazine derivatives
TW546299B (en) 1999-01-07 2003-08-11 Wyeth Corp 3,4-dihydro-2H-benzo[1,4]oxazinyl-methyl-[3-(1H-indol-3-yl)-alkyl]-amines

Also Published As

Publication number Publication date
TWI237023B (en) 2005-08-01
DE60127434T2 (de) 2007-11-29
AR034174A1 (es) 2004-02-04
CN1478092A (zh) 2004-02-25
HUP0301458A2 (hu) 2003-10-28
MXPA03003820A (es) 2003-07-28
IL155520A0 (en) 2003-11-23
ATE357448T1 (de) 2007-04-15
KR20030051747A (ko) 2003-06-25
NO20031838L (no) 2003-06-24
WO2002034754A3 (en) 2002-07-11
JP4242643B2 (ja) 2009-03-25
EP1330460A2 (en) 2003-07-30
WO2002034754A2 (en) 2002-05-02
DE60127434D1 (de) 2007-05-03
JP2004516250A (ja) 2004-06-03
CA2426706A1 (en) 2002-05-02
US20040063704A1 (en) 2004-04-01
EP1330460B1 (en) 2007-03-21
CZ20031163A3 (cs) 2004-04-14
ES2280417T3 (es) 2007-09-16
BR0114881A (pt) 2003-09-30
PL366378A1 (en) 2005-01-24
AU2002224791A1 (en) 2002-05-06
US6939871B2 (en) 2005-09-06

Similar Documents

Publication Publication Date Title
NO20024742D0 (no) Heterocykliske forbindelser, deres fremstilling og anvendelse
NO20015156L (no) 5-pyridyl-1,3-azolforbindelser, deres fremstilling og anvendelse
NO20014603L (no) Tienopyrimidinforbindelser, deres fremstilling og anvendelse
NO20021449L (no) Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og deres anvendelse
NO20012567D0 (no) Azepinoindolderivater, fremstilling og anvendelse derav
DK1455785T3 (da) Substituerede 2-thio-3,5-dicyano-4-phenyl-6-aminopyridiner og deres anvendelse
NO20030596L (no) Benzimidazolderivater, deres fremstilling og terapeutiske anvendelse
DK1419150T3 (da) 1-Phenylsulfonyl-1,3-dihydro-2H-indol-2-on-derivater, deres fremstilling og deres terapeutiske anvendelse
NO20015113D0 (no) Nye forbindelser, deres fremstilling og anvendelse
NO20011956L (no) Substituerte fenylderivater, deres fremstilling og anvendelse
NO20025357L (no) Antranylamider og deres anvendelse som legemidler
DK1161434T3 (da) Pyridopyranoazepinderivater, deres fremstilling og terapeutiske anvendelse
DK1073672T3 (da) Antipicornavirale forbindelser, deres fremstilling og anvendelse
DK1043307T3 (da) 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse
NO20023146D0 (no) Substituerte fenyl-piperazinderivater, deres fremstilling og anvendelse
DK1417189T3 (da) Acylaminothiazolderivater, fremstilling og terapeutisk anvendelse heraf
NO20032234D0 (no) Nye imidazolderivater, deres fremstilling og anvendelse
NO20024107L (no) Tienopyridin derivater, deres fremstilling og anvendelse
DE60144456D1 (de) DibenzoÄb,fÜazepin-Derivate und ihre Herstellung
NO20025209L (no) Cyklipostiner, deres fremstilling og anvendelse
NO20024105D0 (no) Memnopeptider, fremgangsmåte for deres fremstilling og anvendelse av disse
NO20006479D0 (no) Tienopyridinforbindelser, deres fremstilling og anvendelse
NO20001782D0 (no) 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse
NO20012802D0 (no) Benzofuranderivater, deres fremstilling og anvendelse
NO996156L (no) Substituerte cykloheptener, deres fremstilling og anvendelse